scholarly journals Low membranous expression of β-catenin and high mitotic count predict poor prognosis in endometrioid carcinoma of the ovary

2009 ◽  
Vol 23 (1) ◽  
pp. 113-122 ◽  
Author(s):  
Daniel G Rosen ◽  
Zhihong Zhang ◽  
Bin Chang ◽  
Xuemei Wang ◽  
E Lin ◽  
...  
Keyword(s):  
Poor Prognosis ◽  
Mitotic Count ◽  
Endometrioid Carcinoma ◽  
High Mitotic Count ◽  
Carcinoma Of The Ovary

Stage II to IV Low-grade Serous Carcinoma of the Ovary Is Associated With a Poor Prognosis

2013 ◽  
Vol 32 (6) ◽  
pp. 529-535 ◽  
Author(s):  
Rola H. Ali ◽  
Steve E. Kalloger ◽  
Jennifer L. Santos ◽  
Kenneth D. Swenerton ◽  
C. Blake Gilks
Keyword(s):  
Poor Prognosis ◽  
Stage Ii ◽  
Serous Carcinoma ◽  
Low Grade ◽  
Carcinoma Of The Ovary

Endometrioid Carcinoma of the Ovary: A Retrospective Analysis of 106 Cases

1998 ◽  
Vol 84 (5) ◽  
pp. 552-557 ◽  
Author(s):  
Giuseppe Grosso ◽  
Francesco Raspagliesi ◽  
Gabriela Baiocchi ◽  
Emanuela Di Re ◽  
Maria Colavita ◽  
...  
Keyword(s):  
Residual Disease ◽  
Univariate Analysis ◽  
Stage Iv ◽  
Tumor Grade ◽  
Residual Tumor ◽  
Figo Stage ◽  
Lymph Node Status ◽  
Endometrioid Carcinoma ◽  
Synchronous Tumors ◽  
Carcinoma Of The Ovary

Aims and background This report retrospectively analyzes 106 cases of endometrioid carcinoma of the ovary treated at the National Cancer Institute of Milan from 1974 through December 1993. In 12 of the 106 cases (11.3%) a synchronous carcinoma of the uterine body was observed. Methods and study design Only patients who had previously untreated disease were included in the study. Patients with synchronous tumors were staged according to their ovarian cancer and treated according to the stage of that disease. Results Thirty-nine patients (36.8%) had stage I, 17 (16.0%) stage II, 43 (40.6%) stage III, and 7 (6.6%) stage IV disease. Moderately plus poorly differentiated tumors were present in 76 of the 106 cases (71.7%). Considering the 67 patients with advanced disease, residual tumor was absent in 27 cases (40.3%), ≤ 2 cm in 17 (25.4%), and > 2 cm in 23 (34.3%) cases. Systematic pelvic and para-aortic lymphadenectomy was performed in 60 patients (56.6%); selective sampling was carried out in 23 cases (21.7%). After surgery, 77 patients underwent various chemotherapy regimens. Conclusion Using univariate analysis, FIGO stage, tumor grade, residual disease after surgery, lymph node status, and platinum in the chemotherapy regimen significantly influenced 5-year survival. However, when all these variables were included in a multivariate analysis only FIGO stage still had a significant impact on survival. Survival analysis also showed a trend towards longer survival in patients with synchronous tumors.

scholarly journals Argyrophil cells in the endometrioid carcinoma of the ovary

Cancer ◽  
1984 ◽  
Vol 54 (8) ◽  
pp. 1569-1573 ◽  
Author(s):  
Galko Ueda ◽  
Masato Yamasaki ◽  
Masaki Inoue ◽  
Yoshlakl Tanaka ◽  
Keizo Hiramatsu ◽  
...  
Keyword(s):  
Endometrioid Carcinoma ◽  
Argyrophil Cells ◽  
Carcinoma Of The Ovary

The high mitotic count detected by phospho-histone H3 immunostain does not alter the benign behavior of angiocentric glioma

2011 ◽  
Vol 29 (1) ◽  
pp. 68-72 ◽  
Author(s):  
Jian Yi Li ◽  
Lauren A. Langford ◽  
Adekunle Adesina ◽  
Surender R. Bodhireddy ◽  
Min Wang ◽  
...  
Keyword(s):  
Histone H3 ◽  
Mitotic Count ◽  
Angiocentric Glioma ◽  
High Mitotic Count

Squamous cell carcinoma of the ovary: a rare gynecologic tumor with a poor prognosis

2021 ◽  
Vol 162 ◽  
pp. S276-S277
Author(s):  
Dimitrios Nasioudis ◽  
Lakeisha Mulugeta-Gordon ◽  
Maureen Byrne ◽  
Nawar Latif
Keyword(s):  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Squamous Cell ◽  
Poor Prognosis ◽  
Gynecologic Tumor ◽  
Carcinoma Of The Ovary

Sertoliform Endometrioid Carcinoma of the Ovary: A Potential Diagnostic Pitfall

2007 ◽  
Vol 131 (6) ◽  
pp. 979-981
Author(s):  
Anil Misir ◽  
Monalisa Sur
Keyword(s):  
Tumor Cells ◽  
Leydig Cell ◽  
Good Prognosis ◽  
Endometrioid Carcinoma ◽  
Older Population ◽  
Diagnostic Pitfall ◽  
Well Differentiated ◽  
Carcinoma Of The Ovary ◽  
Leydig Cell Tumors ◽  
Usual Pattern

Abstract Sertoliform endometrioid carcinoma of the ovary (SEC) is an uncommon variant that bears histologic similarity to Sertoli and Sertoli-Leydig cell tumors (SLTs). Clinically, SEC affects an older population (60–70 years), while patients with SLT have an average age of 25 years and may exhibit endocrine manifestations. A number of histologic features can be used to distinguish the 2 entities, the most important ones being (1) the presence of areas with the usual pattern of endometrioid carcinoma, and (2) the presence of mucin at the apical borders of the tumor cells. Cytokeratin stains positively, while inhibin and calretinin stain negatively in SEC; the converse is true for SLTs. Based on the clinicopathologic behavior of this entity, SEC should be considered a well-differentiated carcinoma with relatively good prognosis if limited to the ovary.

Endometrioid carcinoma of the ovary

1964 ◽  
Vol 90 (7) ◽  
pp. 936-950 ◽  
Author(s):  
Margaret E. Long ◽  
Howard C. Taylor
Keyword(s):  
Endometrioid Carcinoma ◽  
Carcinoma Of The Ovary
Sign in / Sign up

Export Citation Format

Share Document